A Randomized, Open-Label Extension Study to Investigate the Long-Term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis (MG0004)

April 15, 2021
https://clinicaltrials.gov/ct2/show/NCT04124965
Myasthenia Gravis
Principal Investigator: Kavita M Grover, MD
MG, Myasthenia Gravis, Muscle Weakness, Muscular Diseases, Musculoskeletal Diseases
Accepting Participants
313-916-1364